Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Suppression of glomerulosclerosis by adenovirus-mediated IL-10 expression in the kidney

Abstract

Glomerulosclerosis is a common morphologic result seen in almost all progressed renal diseases, and is the characteristic change in focal segmental glomerulosclerosis (FSGS). The most convincing hypothesis for glomerulosclerosis is cytokine-mediated injury by infiltrating immune cells in the glomerulus and tubulointerstitial area. This study investigated whether the anti-inflammatory effect of interleukin-10 (IL-10) when expressed by a recombinant adenoviral vector can prevent the onset of glomerulosclerosis in FGS/Kist mice (an animal model with naturally occurring renal failure initiated by FSGS). Each group of mice received recombinant adenoviruses encoding human IL-10 (Ad:hIL-10) by intraparenchymal injection at 6 weeks and were examined for cytokine expression, glomerular sclerotic index, and proteinuria. After injection of Ad:hIL-10 to the kidney, IL-10 expression was found to last over 20 days. Mice treated with Ad:hIL-10 were shown to have a significant reduction in the glomerular sclerotic index at 10 weeks when compared to control groups. The level of proteinuria in Ad:hIL-10-treated mice was also significantly reduced. About 50% of the urine samples of naive and Ad:LacZ-treated groups had severe levels of proteinuria. By contrast, at 10 weeks the group treated with Ad:hIL-10 had lower levels of proteinuria and transforming growth factor-β1 (TGF-β1) expression. These results demonstrate that IL-10 effectively prevents the development of glomerulosclerosis in FGS/Kist mice, and IL-10 gene therapy may be of use for the treatment of renal failure.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Kamanna VS, Roh DD, Kirschenbaum MA . Hyperlipidemia and kidney disease: concepts derived from histopathology and cell biology of the glomerulus. Histol Histopathol 1998; 13: 169–179.

    CAS  PubMed  Google Scholar 

  2. Del PD et al. Molecular biology of diabetic glomerulosclerosis. Nephrol Dial Transplant 1998; 13 (Suppl 8): 2025.

    Google Scholar 

  3. Bogenschuz O et al. IgA nephritis; on the importance of morphological and clinical parameters in the long-term prognosis of 239 patients. Am J Nephrol 1990; 10: 137–147.

    Article  Google Scholar 

  4. Wehrmann M et al. Long-term prognosis of focal sclerosing glomerulonephritis. An analysis of 250 cases with particular regard to tubulointerstitial changes. Clin Nephrol 1990; 33: 115–122.

    CAS  PubMed  Google Scholar 

  5. Mackensen-Haen S et al. The consequences for renal function of widening of the interstitium and changes in the tubular epithelium of the renal cortex and outer medulla in various renal diseases. Clin Nephrol 1992; 37: 70–77.

    CAS  PubMed  Google Scholar 

  6. Bohle A et al. Human glomerular structure under normal conditions and in isolated glomerular disease. Kidney Int Suppl 1998; 67: 186S–188S.

    Article  Google Scholar 

  7. Kitching AR et al. Interleukin-4 and interleukin-10 attenuate established crescentic glomerulonephritis in mice. Kidney Int 1997; 52: 52–59.

    Article  CAS  PubMed  Google Scholar 

  8. Baud L, Fouqueray B, Suberville S, Doublier S . Interleukin 10: a logical candidate for suppressing glomerular inflammation? Exp Nephrol 1998; 6: 22–27.

    Article  CAS  PubMed  Google Scholar 

  9. Fiorentino DF, Bond MW, Mosmann TR . Two types of mouse helper T cell IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081–2095.

    Article  CAS  PubMed  Google Scholar 

  10. De Wall MR et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991; 174: 915–924.

    Article  Google Scholar 

  11. Buelens C et al. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur J Immunol 1995; 25: 2668–2672.

    Article  CAS  PubMed  Google Scholar 

  12. Igietseme JU et al. Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: potential for cellular vaccine development. J Immunol 2000; 164: 4212–4219.

    Article  CAS  PubMed  Google Scholar 

  13. Irwin KC, Brouhard BH, Satoh S, Stowe NT . Effects of enalapril on adriamycin-induced nephrosis. Pediatr Nephrol 1992; 6: 448–450.

    Article  CAS  PubMed  Google Scholar 

  14. Tomosugi NI et al. Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1. J Immunol 1989; 142: 3083–3090.

    CAS  PubMed  Google Scholar 

  15. Garber SL, Mirochnik Y, Arrudajose AL, Dunea G . Evolution of experimentally induced papillary necrosis to focal segmental glomerulosclerosis and nephrotic proteinuria. Am J Kidney Dis 1999; 33: 1033–1039.

    Article  CAS  PubMed  Google Scholar 

  16. Taal MW et al. Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney. Kidney Int 2000; 58: 1664–1676.

    Article  CAS  PubMed  Google Scholar 

  17. Ayan S et al. Partial ureteral obstruction dysregulates the renal rennin–angiotensin system in the fetal sheep kidney. Urology 2001; 58: 301–306.

    Article  CAS  PubMed  Google Scholar 

  18. Chen HC, Guh JY, Lai YH . Alterations of glomerular and extracellular glutathione peroxidase levels in patients and rats with focal segmental glomerulosclerosis. J Lab Clin 2001; 137: 279–283.

    Article  CAS  Google Scholar 

  19. Garber SL et al. Relaxin decreases renal interstitial fibrosis and slows progression of renal disease. Kidney Int 2001; 59: 876–882.

    Article  CAS  PubMed  Google Scholar 

  20. Hyun BH, Wakasui N, Saito T, Tomita T . A new mouse strain manifesting high proteinuria and kidney glomerular defect. Lab Anim Sci 1991; 35: 519–526.

    Google Scholar 

  21. Ratscchek M, Ratschek E, Bohle A . Decompensated benign nephrosclerosis and secondary malignant nephrosclerosis. Clin Nephrol 1986; 25: 221–226.

    Google Scholar 

  22. Bohle A, Cavalcanti OD, Laberke HG . Is there any tubular secretion of protein? Clin Nephrol 1998; 29: 28–34.

    Google Scholar 

  23. Bohle A, Mackensen HS, Wehrmann M . Significance of postglomerular capillareis in the pathogenesis of chronic renal failure. Kidney Blood Press Res 1996; 19: 191–195.

    Article  CAS  PubMed  Google Scholar 

  24. Johnson RJ . Platelets in inflammatory glomerular injury. Semin Nephron 1991; 11: 276–284.

    CAS  Google Scholar 

  25. Eddy AA . Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996; 7: 2495–2508.

    CAS  PubMed  Google Scholar 

  26. Engelhardt M, Brennscheidt U, Mertelsmann R, Lindemann A . Interleukin-10 and phenomena of tolerance in interleukin-2 therapy. J Clin Oncol 1996; 14: 1405–1406.

    Article  CAS  PubMed  Google Scholar 

  27. Matsumoto K . Spontaneous and lipopolysaccharide-stimulated secretion of cytokines by peripheral blood monocytes in IgA nephropathy is inhibited interleukin-10. Nephron 1996; 73: 305–309.

    Article  CAS  PubMed  Google Scholar 

  28. Gerritsma JS et al. Expression of the IL-2 receptor on human renal proximal tubular epithelial cells. J Am Soc Nephrol 1997; 8: 1510–1516.

    CAS  PubMed  Google Scholar 

  29. Apparailly F et al. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J Immunol 1998; 160: 5213–5220.

    CAS  PubMed  Google Scholar 

  30. Go NF et al. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J Exp Med 1990; 172: 1625–1631.

    Article  CAS  PubMed  Google Scholar 

  31. Rogy MA et al. Transfer of interleukin-4 and interleukin-10 in patients with severe inflammatory bowel disease of the rectum. Hum Gene Ther 2000; 11: 1731–1741.

    Article  CAS  PubMed  Google Scholar 

  32. Oberholzer C et al. Targeted adenovirus-induced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis. Proc Natl Acad Sci USA 2001; 98: 11503–11508.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Lechman ER et al. Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees. J Immunol 1999; 163: 2202–2208.

    CAS  PubMed  Google Scholar 

  34. Tomita N et al. In vivo administration of a nuclear transcription factor-kappaB decoy suppresses experimental crescentic glomerulonephritis. J Am Soc Nephrol 2000; 11: 1244–1252.

    CAS  PubMed  Google Scholar 

  35. Mastrangeli A et al. ‘Sero-switch’ adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype. Hum Gene Ther 1996; 7: 79–87.

    Article  CAS  PubMed  Google Scholar 

  36. Smith TA et al. Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector. Gene Ther 1996; 3: 496–502.

    CAS  PubMed  Google Scholar 

  37. Schowalter DB et al. Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression. Gene Ther 1997; 4: 853–860.

    Article  CAS  PubMed  Google Scholar 

  38. Bosch RJ, Woolf AS, Fine LG . Gene transfer into mammalian kidney; direct retrovirus-transduction of regenerating tubular epithelial cells. Exp Nephrol 1993; 1: 49–54.

    CAS  PubMed  Google Scholar 

  39. Minter RM et al. Extended lung expression and increased tissue localization of viral IL-10 with adenoviral gene therapy. Proc Natl Acad Sci USA 2001; 98: 277–282.

    Article  CAS  PubMed  Google Scholar 

  40. Watanabe M et al. Intradermal delivery of IL-12 naked DNA induces systemic NK cell activation and Th1 response in vivo that is independent of endogenous IL-12 production. J Immunol 1999; 163:1943–1950.

    CAS  PubMed  Google Scholar 

  41. Pan RY et al. Disease-inducible transgene expression from a recombinant adeno-associated virus vector in a rat arthritis model. J Virol 1999; 73: 3410–3417.

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Moullier P et al. Adenoviral-mediated gene transfer to renal tubular cells in vivo. Kidney Int 1994; 45: 1220–1225.

    Article  CAS  PubMed  Google Scholar 

  43. Zhu G et al. In vivo adenovirus-mediated gene transfer into normal and cystic rat kidneys. Gene Ther 1996; 3: 298–304.

    CAS  PubMed  Google Scholar 

  44. Heikkila P et al. Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system – first steps towards gene therapy of Alport syndrome. Gene Ther 1996; 3: 21–27.

    CAS  PubMed  Google Scholar 

  45. Ye X, Liu X, Ray PE . Efficient gene transfer to rat renal glomeruli with recombinant adenoviral vectors. Hum Gene Ther 2001; 12: 141–148.

    Article  CAS  PubMed  Google Scholar 

  46. Graham FL, Van Der Eb AJ . A new technique for the assay of infectivity of adenovirus 5 DNA. Virology 1973; 52: 456–467.

    Article  CAS  PubMed  Google Scholar 

  47. Mcgrory MJ, Bautista DS, Graham FL . A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 1988; 163: 614–617.

    Article  CAS  PubMed  Google Scholar 

  48. Gilbert SP, Johnson KA . Pre-steady-state kinetics of the microtubule-kinesin ATPase. Biochemistry 1994; 33: 1951–1960.

    Article  CAS  PubMed  Google Scholar 

  49. Saito T, Sumithran E, Glasgow EF, Atkins RC . The enhancement of aminonucleoside nephrosis by the co-administration of protamine. Kidney Int 1987; 32: 691–699.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Drs Beughwa Hyun and Chulholee at Korea Research Institute of Bioscience and Biotechnology, for providing FGS/kist mice for this work. This work was supported by research grants from the SRC of Sunkyunkwan University (MTRC), the Korea Science & Engineering Foundation (R01-2000-00138) and WelGENE Pharmaceuticals Inc., a biotechnology company founded by Dr Park.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Choi, YK., Kim, YJ., Park, HS. et al. Suppression of glomerulosclerosis by adenovirus-mediated IL-10 expression in the kidney. Gene Ther 10, 559–568 (2003). https://doi.org/10.1038/sj.gt.3301926

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301926

Keywords

This article is cited by

Search

Quick links